BioGaia AB Ownership

BIOG-B Stock  SEK 115.60  1.30  1.11%   
BioGaia AB holds a total of 97.28 Million outstanding shares. Over half of BioGaia AB's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in BioGaia AB. Please watch out for any change in the institutional holdings of BioGaia AB as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as BioGaia AB in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of BioGaia AB, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioGaia AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

BioGaia Stock Ownership Analysis

About 50.0% of the company shares are held by institutions such as insurance companies. The book value of BioGaia AB was currently reported as 19.53. The company has Price/Earnings To Growth (PEG) ratio of 1.9. BioGaia AB last dividend was issued on the 9th of May 2022. The entity had 5:1 split on the 18th of May 2022. BioGaia AB develops, markets, and sells probiotic products with documented health benefits worldwide. BioGaia AB was founded in 1990 and is headquartered in Stockholm, Sweden. BioGaia AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 144 people. For more info on BioGaia AB please contact Isabelle Ducellier at 46 8 55 52 93 00 or go to https://www.biogaia.com.

BioGaia AB Outstanding Bonds

BioGaia AB issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BioGaia AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BioGaia bonds can be classified according to their maturity, which is the date when BioGaia AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in BioGaia Stock

BioGaia AB financial ratios help investors to determine whether BioGaia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioGaia with respect to the benefits of owning BioGaia AB security.